News

According to insights, the market for contract development and manufacturing organizations (CDMOs) specializing in small molecule innovation is estimated to reach a value of $48.09 billion in 2023 and $89.43 billion in 2033. The sales in this market are...

Thaerapy BV, a pharmaceutical drug product development company, and Resyca® BV a joint venture of Medspray Pharma BV and Recipharm AB, a leader in the development of soft mist inhalers, announced today the signing of an exclusive license agreement...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced a new partnership with Matador Japan KK, experts in the Japanese pharmaceutical sector, to enable pre-competitive collaboration in the Japanese market. The Alliance and...

Aseptic fill/finish experts Flexicon Liquid Filling, part of Watson-Marlow Fluid Technology Solutions (WMFTS), and barrier technology specialists Franz Ziel GmbH, announces Cellefill™, a turnkey, vial fill/finish system with an integrated barrier solution. Enhancing good manufacturing practice (GMP), customer compliance and...

In Hong Kong, lung cancer continues to be the most prevalent form of cancer. Despite its status as a prominent global cause of cancer-related deaths, there is still a need for a significant breakthrough in its treatment. The Faculty...

Telix Pharmaceuticals Limited opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility located in Belgium. The 2,800 square meter facility is one of Europe's largest radiopharmaceutical production facilities, according to the company. It will serve as Telix’s primary manufacturing site...

Charles River Laboratories International, Inc. and the INADcure Foundation, a nonprofit organization whose mission is to support the development of treatments for Infantile Neuroaxonal Dystrophy (INAD) and other forms of PLA2G6-related neurodegeneration (PLAN), today announced a plasmid DNA manufacturing...